EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bayesian unsupervised clustering identifies clinically relevant osteosarcoma subtypes

Sergio Llaneza-Lago, William D Fraser, Darrell Green iD

Briefings in Bioinformatics · 22.11.2024 · 26 (1)

DOI: 10.1093/bib/bbae665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 20.12.2024. Verfasst von Sergio Llaneza-Lago und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Centre, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, United Kingdom. Hauptthemen laut MEDLINE: Osteosarcoma, Bayes Theorem, Unsupervised Machine Learning. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHILDREN with CANCER UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identification of cancer subtypes is a critical step for developing precision medicine. Most cancer subtyping is based on the analysis of RNA sequencing (RNA-seq) data from patient cohorts using unsupervised machine learning methods such as hierarchical cluster analysis, but these computational approaches disregard the heterogeneous composition of individual cancer samples. Here, we used a more sophisticated unsupervised Bayesian model termed latent process decomposition (LPD), which handles individual cancer sample heterogeneity and deconvolutes the structure of transcriptome data to provide clinically relevant information. The work was performed on the pediatric tumor osteosarcoma, which is a prototypical model for a rare and heterogeneous cancer. The LPD model detected three osteosarcoma subtypes. The subtype with the poorest prognosis was validated using independent patient datasets. This new stratification framework will be important for more accurate diagnostic labeling, expediting precision medicine, and improving clinical trial success. Our results emphasize the importance of using more sophisticated machine learning approaches (and for teaching deep learning and artificial intelligence) for RNA-seq data analysis, which may assist drug targeting and clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBayes TheoremUnsupervised Machine LearningHumansCluster AnalysisBone NeoplasmsPrognosisTranscriptomeGene Expression Profiling

Stichwörter der Autor:innen

RNA-seqheterogeneitylatent process decompositionosteosarcomaprecision medicine

Autor:innen und Institutionen

  • Biomedical Research Centre, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, United Kingdom.
  • Bioanalytical Facility, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, United Kingdom.

ORCID-Profile: Darrell Green

Förderung

  • CHILDREN with CANCER UK

Zitieren

APA

Llaneza-Lago, S., Fraser, W. D., & Green, D. (2024). Bayesian unsupervised clustering identifies clinically relevant osteosarcoma subtypes. Briefings in Bioinformatics, 26(1). https://doi.org/10.1093/bib/bbae665

Vancouver

Llaneza-Lago S, Fraser WD, Green D. Bayesian unsupervised clustering identifies clinically relevant osteosarcoma subtypes. Briefings in Bioinformatics. 2024;26(1). doi:10.1093/bib/bbae665

BibTeX
@article{LlanezaLago2024,
  author = {Llaneza-Lago, Sergio and Fraser, William D and Green, Darrell},
  title = {Bayesian unsupervised clustering identifies clinically relevant osteosarcoma subtypes},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  volume = {26},
  number = {1},
  doi = {10.1093/bib/bbae665}
}
Kostenlos starten →